Urinary epidermal growth factor/monocyte chemotactic peptide 1 ratio as non-invasive predictor of Mayo clinic imaging classes in autosomal dominant polycystic kidney disease.

Maria Teresa RocchettiFrancesco PesceSilvia MatinoGiovanni PiscopoIghli di BariFrancesco TrepiccioneGiovanna CapolongoMaria Antonietta PerniolaXuewen SongSaima KhowajaAmirreza HaghighiDorien PetersSimona PaolicelliPaola PontrelliGiuseppe Stefano NettiElena RanieriGiovambattista CapassoMarco MoschettaYork PeiLoreto Gesualdonull null

Published in: Journal of nephrology (2022)

The ratio of urinary epidermal growth factor and monocyte chemotactic peptide 1 is a non-invasive pathophysiological biomarker that can be used for clinical risk stratification in autosomal dominant polycystic kidney disease.

Keyphrases

growth factor
polycystic kidney disease
dendritic cells
endothelial cells
high resolution
wound healing
peripheral blood
primary care
mass spectrometry
photodynamic therapy
fluorescence imaging